[Surgical strategy for malignant glioma resection with intraoperative use of fluorescein Na]

No Shinkei Geka. 2007 Jun;35(6):557-62.
[Article in Japanese]

Abstract

Cytoreductive surgery is accepted by many neurosurgeons to be the best treatment for patients with malignant gliomas. Resection of a contrast-enhancing lesion on a CT or MR image is a particularly common treatment, because observation of such lesions indicates the presence of viable tumor cells. We have used intravenous injection of fluorescein Na (0.2 cc/kg body weight) as a chemical probe for resection of malignant gliomas. Following this injection, the yellow-stained tumor is visible to the naked eye. For tumors located in an eloquent area, resection is performed at the surface of the yellow-stained tumor, or tumor debulking within the yellow-colored lesion is conducted until the resection surface becomes pale yellow. For tumors located in non-eloquent regions, suction of peritumoral white matter is also required. This procedure requires no special equipment and has wide applicability in resection of malignant gliomas.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Brain Neoplasms / diagnosis
  • Brain Neoplasms / pathology
  • Brain Neoplasms / surgery*
  • Fluorescein*
  • Fluorescent Dyes*
  • Glioma / diagnosis
  • Glioma / pathology
  • Glioma / surgery*
  • Humans
  • Magnetic Resonance Imaging
  • Monitoring, Intraoperative*
  • Tomography, X-Ray Computed

Substances

  • Fluorescent Dyes
  • Fluorescein